We are live on ! Find out more
BOLT icon

Bolt Biotherapeutics
BOLT

71 hedge funds and large institutions have $449M invested in Bolt Biotherapeutics in 2021 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 29 increasing their positions, 11 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

164% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 11

157% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 7

16% more funds holding

Funds holding: 61 → 71 (+10)

0.19% more ownership

Funds ownership: 4.58% → 4.77% (+0.19%)

13% less capital invested

Capital invested by funds: $514M → $449M (-$64.6M)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
1.24%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.07%
New
18
Increased
29
Reduced
11
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SC
Samlyn Capital
New York
+$10.5M
2
BlackRock
BlackRock
New York
+$7.24M
3
SCM
Suvretta Capital Management
New York
+$5.25M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$4.89M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.91M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$2.32M
2
ABG
Ally Bridge Group
New York
-$2.19M
3
SAM
Sectoral Asset Management
Quebec, Canada
-$1.98M
4
Morgan Stanley
Morgan Stanley
New York
-$1.33M
5
Citadel Advisors
Citadel Advisors
Florida
-$1.14M
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
26
Millennium Management
New York
$2.06M +$1.85M +6,558 +410%
EC
27
EcoR1 Capital
California
$1.85M – – –
RI
28
RTW Investments
New York
$1.6M – – –
SAM
29
Sectoral Asset Management
Quebec, Canada
$1.47M -$1.98M -7,013 -55%
DCM
30
DAFNA Capital Management
California
$1.26M – – –
Point72 Asset Management
31
Point72 Asset Management
Connecticut
$1.19M +$1.33M +4,698 New
N
32
Nuveen
North Carolina
$1.14M +$516K +1,827 +68%
ECM
33
Endurant Capital Management
California
$1.14M +$1.27M +4,502 New
Renaissance Technologies
34
Renaissance Technologies
New York
$1M +$266K +941 +31%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$893K +$339K +1,199 +51%
JP Morgan Chase
36
JP Morgan Chase
New York
$861K -$226K -801 -19%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$829K +$684K +2,421 +283%
TCM
38
Tekla Capital Management
Massachusetts
$823K +$919K +3,251 New
Charles Schwab
39
Charles Schwab
California
$663K -$346K -1,226 -32%
Ensign Peak Advisors
40
Ensign Peak Advisors
Utah
$366K +$267K +945 +189%
Swiss National Bank
41
Swiss National Bank
Switzerland
$354K – – –
DCM
42
Dupont Capital Management
Delaware
$338K +$378K +1,337 New
California State Teachers Retirement System (CalSTRS)
43
California State Teachers Retirement System (CalSTRS)
California
$294K +$103K +364 +46%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$271K +$117K +413 +63%
Bank of America
45
Bank of America
North Carolina
$262K +$147K +521 +101%
Deutsche Bank
46
Deutsche Bank
Germany
$244K +$176K +624 +181%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$190K +$38.7K +137 +22%
Qube Research & Technologies (QRT)
48
Qube Research & Technologies (QRT)
United Kingdom
$190K +$212K +750 New
VF
49
Virtu Financial
New York
$184K +$206K +729 New
SG Americas Securities
50
SG Americas Securities
New York
$178K +$199K +704 New
1
2
3 4

BOLT Hedge Fund Activity: Q3 2021 in Review

71 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Bolt Biotherapeutics (BOLT) for Q3 2021, worth a combined $449M — down 13% from $514M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new BOLT positions and 7 closed out — a net gain of 11 holders — while 29 added to existing stakes and 11 trimmed.

The largest buyer was Samlyn Capital, opening a new position worth an estimated $10.5M. The largest seller was Franklin Resources, exiting entirely with an estimated $2.32M sold.

  • 71 institutional investors held Bolt Biotherapeutics (BOLT) as of Q3 2021, up from 61 in Q2 2021.
  • Funds reported $449M of Bolt Biotherapeutics stock for Q3 2021, down 13% quarter-over-quarter.
  • 18 funds opened new Bolt Biotherapeutics positions in Q3 2021 and 7 closed out, a net change of +11 holders.
  • The largest Bolt Biotherapeutics buyer in Q3 2021 was Samlyn Capital, an estimated $10.5M added.
  • The largest Bolt Biotherapeutics seller in Q3 2021 was Franklin Resources, an estimated $2.32M sold.

Based on aggregated 13F filings for Q3 2021.